Coding

Coding the “Spot Check”: Part 2

Author and Disclosure Information

 

References

Let’s look at documentation examples:

  • CC: 1-year follow-up on basal cell carcinoma (BCC) excision and concern about a new spot on the nose.
  • History: Notice new spot on the nose; due for annual follow-up and came early for nose lesion.
  • Examination: Left ala with flesh-colored papule dermoscopically banal. Prior left back BCC excision site soft and supple. Total-body examination performed, except perianal and external genitalia, and is unremarkable.
  • Impression: Fibrous papule of nose and prior BCC treatment site with no sign of recurrence.
  • Plan: Reassure. Annual surveillance in 1 year.

Using what we have previously discussed, this would likely be considered CPT code 99212 (established patient office visit). However, it is important to ensure all concerns and treatment interventions are fully documented. Consider this fuller documentation with bolded additions:

  • CC: 1-year follow-up on BCC excision and concern about a new spot on the nose.
  • History: Notice new spot on the nose; due for annual follow-up and came early for nose lesion. Also unhappy with generally looking older.
  • Examination: Left ala with flesh-colored papule dermoscopically banal. Prior left back BCC excision site soft and supple. Diffuse changes of chronic sun damage. Total-body examination performed, except perianal and external genitalia, and is unremarkable.
  • Impression: Fibrous papule of nose and prior BCC treatment site with no sign of recurrence and heliodermatosis/chronic sun damage not at treat-ment goal.
  • Plan: Reassure. Annual surveillance in 1 year. Over-the-counter broad-spectrum sun protection factor 30+ sunscreen daily.

This is better but still possibly confusing to an auditor. Consider instead with bolded additions to the changes to the impression:

  • CC: 1-year follow-up on BCC excision and concern about a new spot on the nose.
  • History: Notice new spot on the nose; due for annual follow-up and came early for nose lesion. Also unhappy with generally looking older.
  • Examination: Left ala with flesh-colored papule dermoscopically banal. Prior left back BCC excision site soft and supple. Diffuse changes of chronic sun damage. Total-body examination performed, except perianal and external genitalia, and is unremarkable.
  • Impression: Fibrous papule of nose (D22.39)7 and prior BCC treatment site with no sign of recurrence (Z85.828: “personal history of other malignant neoplasm of skin) and heliodermatosis/chronic sun damage not at treatment goal (L57.8: “other skin changes due to chronic exposure to nonionizing radiation”).
  • Plan: Reassure. Annual surveillance 1 year. Over-the-counter broad-spectrum sun protection factor 30+ sunscreen daily.

We now have chronic heliodermatitis not at treatment goal, which is moderate (column 1, level 4), and the over-the-counter broad-spectrum sun protection factor 30+ sunscreen (column 1, low) would be best coded as CPT code 99213.

Final Thoughts

“Spot check” encounters are common dermatologic visits, both on their own and in combination with other concerns. With the updated E/M guidelines, it is crucial to clarify and streamline your documentation. In particular, utilize language clearly defining the number and complexity of problems, data to be reviewed and/or analyzed, and appropriate risk stratification to ensure appropriate reimbursement and minimize your difficulties with audits.

Pages

Recommended Reading

CMS inpatient payment rule for 2024: Key takeaways
MDedge Dermatology
Surgeons, intensivists earn more than do colleagues from private insurance
MDedge Dermatology
Proposed Medicare bill would raise docs’ pay with inflation
MDedge Dermatology
Coding the “Spot Check”: Part 1
MDedge Dermatology
Five ways docs may qualify for discounts on medical malpractice premiums
MDedge Dermatology
Medical students gain momentum in effort to ban legacy admissions
MDedge Dermatology
Inpatient Dermatology Consultation Services in Hospital Institutions
MDedge Dermatology
AI at the office: Are clinicians prepared?
MDedge Dermatology
States move to curb insurers’ prior authorization requirements as federal reforms lag
MDedge Dermatology
As Medicaid purge begins, ‘staggering numbers’ of Americans lose coverage
MDedge Dermatology